Genetic and molecular analysis in Arabidopsis has identified components of a putative cell signalling pathway that appears to regulate the balance between stem cell proliferation and fate specification in meristems.
Plant development differs in important respects from animal development, notably in that, whereas most animal organs are formed during embryogenesis, the aboveground parts of higher plants arise post-embryonically from apical meristems at their growing tips. Each meristem typically consists of a dome of slowly dividing stem cells. Daughter cells near the apex of the dome retain stem cell identity, whereas those left behind by growth and division of cells above them assume different fates as initials of lateral organs such as leaves or petals, secondary meristems or stem tissue ( Figure 1 ). The population of stem cells has been proposed to correspond to the central zone of the apex, and is associated with lower rates of cell division than in the flanking peripheral zone, where lateral organs arise. According to this model, for the meristem to be maintained, the cell divisions in the central zone that renew the stem cell population must occur at such a rate as to balance entry into the peripheral zone. This balance may change during normal development of the plant, most dramatically in the determinate growth of flowers, where cells at the centre of the meristem go to form the female sex organs -the carpels or gynoecium -and ultimately differentiate, so terminating growth. So what mechanisms regulate the balance? This question is particularly intriguing because the meristem consists of multiple histogenic layers -usually three occur in broad-leaved plants, termed L1-3 -which, from early embryogenesis, remain clonally distinct. Growth of the internal cell layer, L3, matches that in the overlying cell layers, L2 and L1, suggesting that communication between cells in the different layers must occur.
Insights into the regulation of normal meristem function have come from genetic analysis in Arabidopsis. Plants mutant for any one of three CLAVATA genes -CLV1, CLV2 or CLV3 -have larger shoot apical meristems than normal because of an increased number of cells within the central zone, suggesting that the CLV genes function either to repress proliferation of stem cells within the central zone or to promote entry into the peripheral zone, or both [1] [2] [3] . The results of epistasis experimentswhich test the effects of combining mutations -suggest that CLV1 and CLV3 function in a common developmental pathway [4] , because the double mutants are similar in severity to either single mutant. Although less characterized, CLV2 is also likely to act in this pathway.
The increased size of clv mutant meristems is apparent in the embryo and becomes more exaggerated as the plant grows, resulting in broader or fasciated (ribbon-shaped) stems and altered positioning of lateral organs around the stem axis. The lateral organs themselves, however, remain relatively unaffected in clv mutants, suggesting that the CLV pathway is not required in their subsequent development. Cells in the central zone of the floral meristem, which in wild-type plants would differentiate to produce the gynoecium, proliferate in clv mutants to form additional whorls of carpelloid organs or large masses of meristematic tissues. This loss of determinacy provides further support for the proposed roles of the CLV genes in regulating the balance between stem cell proliferation and differentiation.
In contrast to the CLV pathway, which appears to have a role in repressing meristem growth, other genes have been identified as necessary for promoting meristem activity in Arabidopsis. The best characterized of these is SHOOT Structure of a shoot apical meristem. Cell division in the L1 and L2 layers is anticlinal -perpendicular to the surface -so that these layers seldom contribute progeny to other layers and thus remain clonally distinct lineages. The region proposed to correspond to a central zone of stem cells is indicated (CZ), as is the peripheral zone (PZ) where lateral organs or meristems initiate. MERISTEMLESS (STM), which encodes a homeobox protein and is required for formation of the shoot apical meristem during embryogenesis and subsequent maintenance of the stem cell population in indeterminate meristems (the meristems of weak stm mutants frequently differentiate as lateral organs) [5] [6] [7] . STM is expressed in all cell layers of the meristem, but not in initials of lateral organs or secondary meristems, a pattern compatible with the role for STM, although whether expression is confined to the putative stem cell population of the central zone is not clear. The phenotypes of plants carrying multiple mutations suggest that STM acts antagonistically to the CLV pathway [7] .
As an important first step in the molecular analysis of these genes, Clark et al. [8] have recently isolated the CLV1 gene using a map-based cloning strategy. Genetic mapping showed that CLV1 is closely linked to a previously isolated molecular marker. This provided a molecular probe to isolate yeast artificial chromosome (YAC) and cosmid clones carrying nearby genomic DNA, and the CLV gene was subsequently shown by complementation analysis to reside on a single cosmid. Further complementation analysis using small regions of the cosmid, together with sequence analysis of clv mutant alleles, served to pinpoint the CLV1 gene.
The sequence of CLV1 proved particularly revealing, as its putative product contains a series of discrete domains with the characteristic arrangement found in receptor protein kinases, a large class of animal and plant proteins that are typically involved in cell signalling (Figure 2 ). Such proteins generally have an extracellular receptor domain required for ligand binding, a transmembrane domain and a cytoplasmic kinase domain, with the precise nature of the receptor and kinase domains varying between families. In the case of CLV1, the extracellular domain comprises 21 repeats of a short sequence rich in leucine residues. Similar leucine-rich repeats (LRRs) are found in receptors that bind glycoprotein hormones in animals, and several plant proteins that mediate disease resistance by recognizing pathogen-specific ligands [9] . Given what is known of the animal receptor kinases, a likely scenario for CLV1 action is that the protein's LRR domain binds an extracellular ligand, and that this causes conformational changes leading to receptor dimerization and the activation of the kinase domain. Activation may lead to autophosphorylation, in which each subunit of the dimer phosphorylates its partner, and thereby to activation of downstream components of a signalling pathway.
Further insight comes from the characterization of a series of clv1 alleles [8] . The most severe alleles all have mutations in the extracellular LRR domain which presumably block signalling by interfering with the ability of CLV1 either to recognize and bind its ligand, or to dimerize following binding. Mutations in the kinase domain, in contrast, give much weaker phenotypes, suggesting that there is some redundancy in the kinase activity, as for example might occur if the CLV1 protein can associate with additional kinases. Curiously, although several of the clv1 alleles are semi-dominant, it is the weak alleles that have strongest effects when heterozygous with wild-type alleles. Similar dominant-negative interactions have been observed for kinase mutations in receptor kinases from animals, and may result from formation of a 'poisoned complex' -for example, if the mutant protein associates with a wild-type partner, but is unable to phosphorylate it, thereby abrogating activity of the complex.
Where, then, does CLV1 act? And does it act by repressing stem cell proliferation at the summit of the meristem or by promoting fate specification in the periphery, or both? The expression pattern of CLV1 during inflorescence development is intriguing, because CLV1 RNA is confined to the centre of the shoot apical meristem and is absent from the sites of presumptive floral meristems on its flanks. As floral meristems develop and initiate floral organs, CLV1 RNA reappears, then becomes progressively restricted to the centre of the floral meristem, and eventually disappears around the time that the gynoecium is initiated [8] . Because the distribution of the putative CLV1 ligand is unknown, it is unclear whether CLV1 is activated in all cells in which it is expressed or in just a subset of them.
Nonetheless, the localization of CLV1 expression to the centre of the meristem seems most easily reconciled with the view that CLV1 acts to repress stem cell proliferation. The cloning of CLV1 should permit further testing of such a model. For several animal receptor kinases, mutations are known that lead to constitutive activation of the kinase domain and thus of the downstream signalling pathway. By engineering similar CLV1 mutations, and inducing expression of the mutant construct in transgenic plants, it may be possible to test the effects of activating CLV1 throughout meristems. Alternatively, swapping the extracellular domains between CLV1 and other plant receptor kinases, such as those encoded by disease resistance genes, may allow inducible activation of the CLV1 kinase. A further curiosity of CLV1 RNA expression is that it is absent from the L1 cell layer and much or all of the L2 layer. Assuming that the CLV1 protein is similarly restricted, this raises the possibility that CLV1 is involved in coordinating the growth of the separate cell layers, for example by responding to a signal from cells in the L1 and/or L2 layers.
Much interest now focuses on the nature and expression pattern of the CLV1 ligand. Does CLV1 respond to a signal that moves outwards from the centre of the meristem to limit cell division? Or do genes that specify fate on the flanks of the meristem somehow induce a signal back to the summit? Further dissection of the CLV signalling pathway will come from the molecular characterization of CLV2 and CLV3, which are promising candidates for the gene encoding the ligand that activates the CLV1 receptor -particularly so in the case of CLV3, which shows dominant genetic interactions with CLV1 suggesting that their products are likely to act together [4] .
What next? The STM and CLV1 genes, which act competitively, have largely overlapping expression domains in meristems. Because neither gene is fully epistatic to the other, CLV1 cannot exclusively regulate STM or vice versa. The characterization of the downstream targets of these genes may help integrate the pathways in the near future, for example if the two genes turn out to act on common targets. The similarity of CLV1 to plant disease resistance receptors is also striking. As the pathogen resistance and dorsal-ventral patterning pathways in Drosophila appear to have evolved from a common pathway [10] , it will be interesting to discover whether the downstream components of plant disease resistance and CLV pathways are also similar.
